Operating Segments and Related Information (Tables)

9 Months Ended

Sep. 30, 2012

Operating Segments and Related Information [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following table presents certain continuing operating division information in accordance with the provisions of ASC 280, “Segments Reporting.”

(in thousands)	Solar			Biomedical		Total Company
For the three months ended September 30, 2012
Net sales and revenues	$	2,485		$	1,743	$	4,228
Operating income (loss) from continuing operations	$	(2,197	)	$	179	$	(2,018	)
For the three months ended September 30, 2011
Net sales and revenues	$	6,177		$	2,003	$	8,180
Operating income (loss) from continuing operations	$	(1,437	)	$	392	$	(1,045	)
For the nine months ended September, 2012
Net sales and revenues	$	13,219		$	5,104	$	18,323
Operating income (loss) from continuing operations	$	(5,740	)	$	326	$	(5,414	)
For the nine months ended September 30, 2011
Net sales and revenues	$	33,610		$	6,169	$	39,779
Operating income (loss) from continuing operations	$	(2,197	)	$	1,115	$	(1,082	)

Revenues By Geography [Table Text Block]

The following table shows net sales and revenues by geographic area (based on customer location):

	Three Months Ended September 30,								Nine Months Ended September 30,
(in thousands)	2012		%		2011		%		2012		%		2011		%
United States	$	3,005	71	%	$	2,436	30	%	$	7,955	43	%	$	16,598	42	%
Europe/Africa	376		9		1,231		15		3,062		17		3,792		9
Asia	839		20		4,454		54		7,246		40		17,427		44
Rest of the world	8		—		59		1		60		—		1,962		5
	$	4,228	100	%	$	8,180	100	%	$	18,323	100	%	$	39,779	100	%